mynth
← DATABASE
09/2026100%

Nestlé VMS business acquired by Yellow Wood Partners

SWITZERLAND Life Sciences / Nutrition & Dietary Supplements EV $1–10bn

Context

Announced in September 2026, the corporate carve-out agreement entered into between Yellow Wood Partners and Nestlé executes the acquisition of Nestlé's mainstream vitamins, minerals, and supplements business, designated as the Holistic Health portfolio. The transaction involves Yellow Wood Partners acquiring full ownership of the target business, which generated annual turnover of $1–10bn in 2025. Structurally, the divestiture encompasses the complete transfer of seven mainstream consumer supplement brands alongside dedicated manufacturing, packaging, warehousing, and distribution infrastructure. Under the leadership of Chief Executive Officer Philipp Navratil, the divestment enables Nestlé to refocus corporate capital and research capabilities on premium, science-led health and wellness categories, retaining specialized brands such as Solgar and Pure Encapsulations. For Yellow Wood Partners, represented by partner Tad Yanagi, the investment thesis focuses on applying the firm's Consumer Operating DNA framework to scale the acquired portfolio as an independent corporate entity, addressing expanding consumer adoption across functional health, joint health, hydration, and nutritional wellness. The integration strategy aims to capture organic growth across mass retail, pharmacy, and grocery channels, utilizing the acquired private-label manufacturing capacity to support contracted product supply agreements. The completion of this cross-border carve-out remains subject to applicable regulatory clearances and customary closing conditions, with final closing projected for the first half of 2027.

-> Deep-dive in Healthcare & Pharma market trends

Target

Founded in Vevey, the Nestlé VMS (Vitamins, Minerals and Supplements) business operates a mainstream vitamins, minerals and supplements portfolio serving the general‑consumer market. The unit comprises seven established brands—Nature’s Bounty, Osteo Bi‑Flex, Ester‑C, Gard, Nuun, Puritan’s Pride and Sisu—plus a private‑label supplement line in the United States. It maintains dedicated manufacturing, packaging, warehousing and distribution facilities that support sales primarily in the U.S., with additional presence in Canada and China. The business model combines brand ownership with in‑house production and logistics, enabling direct supply to retail channels and e‑commerce platforms. By integrating formulation, quality control, and packaging under one operational umbrella, the company delivers a consistent product range across multiple dosage forms while leveraging scale in procurement and distribution. The operation employs a workforce spread across manufacturing sites and distribution centres, and it manages a supply chain that sources raw ingredients, conducts blending and encapsulation, and distributes finished goods to national and international retailers.

Ent. Value

$1–10bn

Equity Value

[members only]

Multiples

EV / Revenue

below 1.5x

EV / EBITDA

[members only]

EV / EBIT

[members only]

Historical Financials (USD)

Year
Rev
EBITDA
EBIT
2025
$1–10bn
[members only]
[members only]
2024
$1–10bn
[members only]
[members only]

Other operations with Nestle

Other operations with Nestle
DateAcquirerTargetCountrySector
07/2026PLATINUM EQUITY / NESTLEPERANEL EX NESTLE WATERFRANCESoft Drinks
06/2026NESTLEYFOOD LABSGERMANYFood Products
05/2021NESTLENUUNUNITED STATESSoft Drinks
04/2021NESTLETHE BOUNTIFUL COMPANYUNITED STATESNutrition & Dietary Supplements
02/2021SILVER LAKE / NESTLEIVC EVIDENSIAUNITED KINGDOMVet Clinics
09/2020NESTLEIM HEALTHSCIENCEUNITED STATESNutrition & Dietary Supplements
09/2017NESTLESWEET EARTHUNITED STATESFood Products

Similar deals in Life Sciences

Similar deals in Life Sciences
DateAcquirerTargetCountrySector
10/2026APHEONHAGER & MEISINGERGERMANYMedical Consumables
10/2026NEXTSTAGECORAVIAFRANCEMedical Consumables
09/2026TELIX PHARMACEUTICALSITM ISOTOPE TECHNOLOGIESGERMANYPharma & Biotech
08/2026TELEDYNE TECHNOLOGIES INCORPORATEDVAREX IMAGINGUNITED STATESDiagnostic Equipment
08/2026ZIMMER BIOMETMONOGRAM TECHNOLOGIESUNITED STATESMedical Devices
08/2026WISE EQUITYE-PHARMA TRENTOITALYCDMO
08/2026STADAORIFARM VMSDENMARKNutrition & Dietary Supplements
08/2026KKRINTEGERUNITED STATESMedical Devices
07/2026INFLEXIONPRIMEDGERMANYMedical Consumables
07/2026BAIN CAPITALVITABIOTICSUNITED KINGDOMNutrition & Dietary Supplements

REFERENCES

Valuation range: EV $1–10bn

Revenue range: $1–10bn

EV/Revenue range: below 1.5x

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Nestlé VMS business by Yellow Wood Partners are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Target: nestlé vms business

FAQ

What transaction does this page cover?

This page covers Yellow Wood Partners’s acquisition of 100% of Nestlé VMS business, a Swiss company specialised in Nutrition & Dietary Supplements, in 2026. This followed an earlier holding cycle initiated in July 2026, when the company was acquired by Platinum Equity / Nestle.

How was the acquisition of Nestlé VMS business by Yellow Wood Partners valued, and what multiples were paid?

mynth displays the transaction’s enterprise value within the $1–10bn band and its EV/revenue multiple within the below 1.5x range. Exact figures are available to members.

What was Nestlé VMS business’s revenue at the time of the deal?

At the time of the transaction, Nestlé VMS business’s annual revenue was estimated within the $1–10bn range (FY 2025). Detailed financial figures are available to members.

What sources support the information on this transaction?

The details of this transaction are sourced directly from the official corporate announcement published on the parties’ institutional website, ensuring primary-source verification of the closing and perimeter.

What is mynth?

mynth is the first free M&A database dedicated to Small & Mid-Cap transactions. We centralize Enterprise Values, revenue multiples, EBITDA multiples and transaction financials that are typically locked behind five-figure subscriptions on platforms like Capital IQ or Mergermarket. On mynth, searching and browsing deals is completely free. Our mission is simple: make professional-grade valuation intelligence accessible to every M&A advisor, independent consultant, Private Equity professional and student, without the burden of expensive annual licenses.